摘要
藏药绿绒蒿属于罂粟科,主要成分包含生物碱、黄酮类、萜类、甾体、挥发油和微量元素等,功效包括活血、化瘀、止痛、治头伤和骨折等,而现代药理学研究发现其在心肌梗死、肿瘤、肝炎、帕金森综合征和阿尔兹海默病等多种疾病和病理生理过程中具有较好疗效,已成为传统医学的研究热点。因此,本文主要对绿绒蒿属的现代药理作用在疾病中的研究进展进行分析和总结,以期为绿绒蒿属在基础医学和临床研究的顺利开展提供实验依据,为疾病的治疗提供新思路。
The Tibetan medicine Meconopsis belongs to the Papaveraceae family. Its main components include alkaloids, flavonoids, terpenoids, steroids, volatile oils and trace elements. Its effects include pro-moting blood circulation, removing blood stasis, relieving pain, treating head injuries and fractures, etc. Modern pharmacology scientific research has found that it has good curative effect in various diseases and pathophysiological processes such as myocardial infarction, tumor, hepatitis, Parkin-son’s syndrome and Alzheimer’s disease, and has become a research hotspot of traditional medi-cine. Therefore, this article mainly analyzes and summarizes the research progress of modern pharmacological effects of Meconopsis in diseases, in order to provide experimental basis for the smooth development of basic medicine and clinical research of Meconopsis, and provide new ideas for the treatment of disease.
出处
《临床医学进展》
2022年第9期8508-8514,共7页
Advances in Clinical Medicine
